Allogeneic hematopoietic cell transplantation remains the single most powerful weapon in the fight against higher-risk acute ...
More than 90% of children born with the rare bone marrow condition Shwachman-Diamond syndrome (SDS) survive beyond age 20.
Acute myeloid leukemia (AML) is a genetically heterogeneous hematologic malignancy with frequent relapses and poor outcomes despite advances in chemotherapy, hematopoietic stem cell transplantation ...
Phase I Study of Mosperafenib, a Novel Paradox Breaker B-Raf Proto-Oncogene Serine/Threonine Kinase (BRAF) Inhibitor, in Patients With BRAF V600–Mutant Solid Tumors In a prospective, multicenter phase ...
This phase 2 trial evaluated peripheral blood stem cell transplantation using HLA-mismatched unrelated donors in patients with myeloid leukemia.
Clonal hematopoiesis (CH) is a condition where a portion of hematopoietic stem cells in the bone marrow begin to produce ...
When does it stop working?Anticancer drugs often work well, making leukemia cells disappear from the bone marrow. In the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results